RETROPERITONEAL ABSCESS

This adverse event was reported 316 times

These drugs are most commonly taken by patients reporting RETROPERITONEAL ABSCESS:

# Drug Count
0 PREDNISONE 33
1 PREDNISOLONE 31
2 PREDNISOLONE ORAL 31
3 PREDNISOLONE ORAL SOLUTION 31
4 TACROLIMUS 25
5 BEVACIZUMAB 23
6 INFLIXIMAB 22
7 TACROLIMUS EXTENDED-RELEASE CAPSULES 22
8 TACROLIMUS OINTMENT 0.1% 22
9 ADALIMUMAB 20
See all common drugs associated with RETROPERITONEAL ABSCESS

RETROPERITONEAL ABSCESS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 3% SODIUM CHLORIDE 1 0.0088
1 DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM 3 0.0080
2 BEVACIZUMAB-MALY 1 0.0050
3 BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE 1 0.0040
4 BENZOCAINE AND MENTHOL 1 0.0038
5 ETHIODIZED OIL 2 0.0015
6 CETYLPYRIDINIUM CHLORIDE 1 0.0015
7 DIAZOXIDE 1 0.0014
8 CASPOFUNGIN ACETATE 2 0.0013
9 TAFASITAMAB-CXIX 1 0.0011
See all drugs enriched for association with RETROPERITONEAL ABSCESS